End-of-day quote
Taipei Exchange
23:00:00 22/05/2024 BST
|
5-day change
|
1st Jan Change
|
20.5
TWD
|
+1.23%
|
|
+2.50%
|
+1.49%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,228
|
1,209
|
1,098
|
1,118
|
1,032
|
1,022
|
Enterprise Value (EV)
1 |
733.4
|
931.7
|
524.6
|
689.7
|
651.8
|
634.6
|
P/E ratio
|
34.4
x
|
95.6
x
|
43.4
x
|
-16.7
x
|
-16
x
|
-43.9
x
|
Yield
|
2.8%
|
2.09%
|
2.12%
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.78
x
|
0.89
x
|
0.94
x
|
1.27
x
|
1.48
x
|
1.49
x
|
EV / Revenue
|
0.47
x
|
0.68
x
|
0.45
x
|
0.78
x
|
0.94
x
|
0.92
x
|
EV / EBITDA
|
7.68
x
|
111
x
|
8.11
x
|
-13.8
x
|
-8.42
x
|
-12.8
x
|
EV / FCF
|
-5.32
x
|
39.3
x
|
3.56
x
|
-42.2
x
|
-16.9
x
|
-759
x
|
FCF Yield
|
-18.8%
|
2.55%
|
28.1%
|
-2.37%
|
-5.91%
|
-0.13%
|
Price to Book
|
1.29
x
|
1.3
x
|
1.17
x
|
1.33
x
|
1.3
x
|
1.29
x
|
Nbr of stocks (in thousands)
|
50,581
|
50,581
|
50,581
|
50,581
|
50,581
|
50,581
|
Reference price
2 |
24.27
|
23.90
|
21.70
|
22.10
|
20.40
|
20.20
|
Announcement Date
|
29/03/19
|
30/03/20
|
31/03/21
|
31/03/22
|
31/03/23
|
22/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,573
|
1,362
|
1,163
|
878.8
|
697.1
|
687.3
|
EBITDA
1 |
95.46
|
8.414
|
64.66
|
-49.91
|
-77.38
|
-49.54
|
EBIT
1 |
71.88
|
-19.57
|
37.03
|
-72.66
|
-96.87
|
-60.41
|
Operating Margin
|
4.57%
|
-1.44%
|
3.18%
|
-8.27%
|
-13.9%
|
-8.79%
|
Earnings before Tax (EBT)
1 |
76.17
|
22.45
|
49.75
|
-75.14
|
-87.3
|
-38.33
|
Net income
1 |
35.73
|
12.76
|
25.54
|
-66.82
|
-64.48
|
-23.08
|
Net margin
|
2.27%
|
0.94%
|
2.2%
|
-7.6%
|
-9.25%
|
-3.36%
|
EPS
2 |
0.7064
|
0.2500
|
0.5000
|
-1.321
|
-1.275
|
-0.4600
|
Free Cash Flow
1 |
-137.8
|
23.72
|
147.2
|
-16.36
|
-38.49
|
-0.8361
|
FCF margin
|
-8.76%
|
1.74%
|
12.65%
|
-1.86%
|
-5.52%
|
-0.12%
|
FCF Conversion (EBITDA)
|
-
|
281.89%
|
227.58%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
185.81%
|
576.1%
|
-
|
-
|
-
|
Dividend per Share
2 |
0.6796
|
0.5000
|
0.4600
|
-
|
-
|
-
|
Announcement Date
|
29/03/19
|
30/03/20
|
31/03/21
|
31/03/22
|
31/03/23
|
22/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
494
|
277
|
573
|
428
|
380
|
387
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-138
|
23.7
|
147
|
-16.4
|
-38.5
|
-0.84
|
ROE (net income / shareholders' equity)
|
3.31%
|
0.78%
|
1.93%
|
-7.89%
|
-8.76%
|
-3.64%
|
ROA (Net income/ Total Assets)
|
3.08%
|
-0.86%
|
1.56%
|
-3.25%
|
-4.83%
|
-3.11%
|
Assets
1 |
1,159
|
-1,485
|
1,633
|
2,059
|
1,336
|
741.8
|
Book Value Per Share
2 |
18.80
|
18.40
|
18.60
|
16.60
|
15.70
|
15.70
|
Cash Flow per Share
2 |
9.690
|
8.270
|
11.30
|
8.260
|
7.780
|
8.700
|
Capex
1 |
22.6
|
6.38
|
7.94
|
4.43
|
6.19
|
2.87
|
Capex / Sales
|
1.44%
|
0.47%
|
0.68%
|
0.5%
|
0.89%
|
0.42%
|
Announcement Date
|
29/03/19
|
30/03/20
|
31/03/21
|
31/03/22
|
31/03/23
|
22/03/24
|
|
1st Jan change
|
Capi.
|
---|
| +1.49% | 31.71M | | +8.65% | 45.08B | | -0.86% | 18.35B | | -5.85% | 4.06B | | +3.08% | 3.61B | | +7.49% | 2.72B | | -19.00% | 1.51B | | +55.15% | 1.4B | | +14.09% | 943M | | +21.24% | 800M |
Sanitary Products
|